Lexaria Bioscience - Warrants (11/01/2026) OverviewLexaria Bioscience - Warrants (11/01/2026) EBIT
EBIT (Earnings Before Interest and Taxes) analysis for LEXXW.
Quarterly EBIT
-$1.45M
↑ 47.22% YoY
As of Feb 28, 2026
Annual EBIT (TTM)
-$9.50M
↓ 1.6% YoY
Trailing 12 months ending Feb 28, 2026